Introducing a panel for early detection of lung adenocarcinoma by using data integration of genomics, epigenomics, transcriptomics and proteomics.

[1]  Qiong Zhang,et al.  GSCALite: a web server for gene set cancer analysis , 2018, Bioinform..

[2]  Yuan Zhou,et al.  HMDD v3.0: a database for experimentally supported human microRNA–disease associations , 2018, Nucleic Acids Res..

[3]  Yingyong Hou,et al.  Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer. , 2018, Lung cancer.

[4]  A. Boddy,et al.  The role of solute carrier (SLC) transporters in actinomycin D pharmacokinetics in paediatric cancer patients , 2018, European Journal of Clinical Pharmacology.

[5]  F. Hirsch,et al.  Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules. , 2018, Journal of thoracic disease.

[6]  Jing Li,et al.  Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer. , 2018, Oncology letters.

[7]  Jingcheng Yang,et al.  Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types , 2017, Oncotarget.

[8]  Shumei Wang,et al.  Human transporters, PEPT1/2, facilitate melatonin transportation into mitochondria of cancer cells: An implication of the therapeutic potential , 2017, Journal of pineal research.

[9]  Xiaohui Ren,et al.  DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma , 2017, Oncotarget.

[10]  Ling Zhou,et al.  Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth , 2016, Cell Death & Disease.

[11]  J. Herman,et al.  Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum , 2016, Clinical Cancer Research.

[12]  Allison P. Heath,et al.  Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.

[13]  A. Inga,et al.  c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma , 2016, Oncotarget.

[14]  H. Husi,et al.  Proteomic identification of potential cancer markers in human urine using subtractive analysis. , 2016, International journal of oncology.

[15]  T. Ma,et al.  MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer , 2016, Cellular Physiology and Biochemistry.

[16]  Jianhua Wang,et al.  The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis. , 2016, Carcinogenesis.

[17]  Kai Xu,et al.  MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer. , 2016, Journal of gene therapy.

[18]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[19]  Sung-Hoon Kim,et al.  Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative “omic” profiling of affected neuroendocrine carcinomas , 2015, Molecular carcinogenesis.

[20]  Yan-bin Zhao,et al.  MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC , 2015, Scientific Reports.

[21]  D. Beer,et al.  A Novel Serum 4-microRNA Signature for Lung Cancer Detection , 2015, Scientific Reports.

[22]  Xiaojian Zhao,et al.  MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer , 2015, Cytogenetic and Genome Research.

[23]  C. Bai,et al.  Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers. , 2015, Clinical lung cancer.

[24]  Michael Peyton,et al.  Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. , 2015, Cancer discovery.

[25]  Jianing Li,et al.  miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer. , 2015, Acta biochimica et biophysica Sinica.

[26]  Hua Lu,et al.  Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening , 2015, Tumor Biology.

[27]  L. Andrade,et al.  p16INK4a expression as a potential marker of low‐grade cervical intraepithelial neoplasia progression , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[28]  Guangchuang Yu,et al.  DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis , 2015, Bioinform..

[29]  W. Seeger,et al.  Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. , 2015, American journal of respiratory and critical care medicine.

[30]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[31]  Sanjay K. Nigam,et al.  What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.

[32]  J. O’Sullivan,et al.  Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus. , 2014, Cancer letters.

[33]  Songbin Fu,et al.  microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. , 2014, European journal of cancer.

[34]  Weina Li,et al.  Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer. , 2014, Biochemical and biophysical research communications.

[35]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[36]  F. López-Ríos,et al.  MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer , 2014, PloS one.

[37]  Can Liu,et al.  The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells , 2014, PloS one.

[38]  Elyzabeth A. Portari,et al.  Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population , 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[39]  Lin Jiang,et al.  Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer. , 2014, Gene.

[40]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[41]  X. Qiu,et al.  MicroRNA Hsa-miR-125a-3p Activates p53 and Induces Apoptosis in Lung Cancer Cells , 2013, Cancer investigation.

[42]  Jun Li,et al.  TCPA: a resource for cancer functional proteomics data , 2013, Nature Methods.

[43]  L. Xue,et al.  miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor , 2013, PloS one.

[44]  Martin Reczko,et al.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..

[45]  Wanyi Tai,et al.  Expression profile and functional activity of peptide transporters in prostate cancer cells. , 2013, Molecular pharmaceutics.

[46]  Yoo Jin Jung,et al.  The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.

[47]  C. K. Hsiao,et al.  miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets , 2012, PloS one.

[48]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[49]  Hua-jun Hu,et al.  MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells. , 2012, Acta biochimica et biophysica Sinica.

[50]  A. Schetter,et al.  Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.

[51]  K. Soliman,et al.  Pericellular pH homeostasis is a primary function of the Warburg effect: Inversion of metabolic systems to control lactate steady state in tumor cells , 2012, Cancer science.

[52]  H. Long,et al.  Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549 , 2012, Molecules and cells.

[53]  A. Luttun,et al.  Quantification of miRNA-mRNA Interactions , 2012, PloS one.

[54]  A. Kajdacsy-Balla,et al.  Fractalkine Receptor CX3CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells , 2011, Molecular Cancer Research.

[55]  Suzy V. Torti,et al.  An iron regulatory gene signature predicts outcome in breast cancer. , 2011, Cancer research.

[56]  X. Chen,et al.  Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis , 2011, International journal of cancer.

[57]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[58]  Erik Vassella,et al.  miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner , 2011, Molecular Cancer.

[59]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[60]  Shuji Ogino,et al.  Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review , 2011, International journal of cancer.

[61]  Hanbo Chen,et al.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R , 2011, BMC Bioinformatics.

[62]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[63]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[64]  Feng Jiang,et al.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers , 2010, International journal of cancer.

[65]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[66]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[67]  E. Wang,et al.  Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells , 2010, BMC Cancer.

[68]  Alexander van Oudenaarden,et al.  Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures. , 2010, Molecular cell.

[69]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[70]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[71]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[72]  A. Richmond,et al.  Chemokines and chemokine receptors: new insights into cancer-related inflammation. , 2010, Trends in molecular medicine.

[73]  Hong Peng,et al.  Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. , 2010, Lung cancer.

[74]  Zhenzhong Wang,et al.  Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors , 2009, Journal of chemotherapy.

[75]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[76]  Shu Zheng,et al.  Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer , 2009, The FEBS journal.

[77]  E. Wang,et al.  [hsa-miR-125a-5p Enhances Invasion Ability in Non-Small Lung Carcinoma Cell Lines.]. , 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[78]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[79]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[80]  Martin Reczko,et al.  The database of experimentally supported targets: a functional update of TarBase , 2008, Nucleic Acids Res..

[81]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[82]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[83]  Chau-Chyun Sheu,et al.  Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. , 2006, Oncology reports.

[84]  Yvonne Tay,et al.  A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.

[85]  S. Takeno,et al.  PIK3CA and TFRC Located in 3q Are New Prognostic Factors in Esophageal Squamous Cell Carcinoma , 2006, Annals of Surgical Oncology.

[86]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[87]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[88]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[89]  Praveen M. Bahadduri,et al.  Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. , 2005, American journal of respiratory cell and molecular biology.

[90]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[91]  N. Dolloff,et al.  CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells , 2004, Cancer Research.

[92]  M. Büchler,et al.  Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. , 2004, European journal of cancer.

[93]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[94]  C. Carpenter,et al.  DNA methylation analysis: a powerful new tool for lung cancer diagnosis , 2002, Oncogene.

[95]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[96]  D. Groneberg,et al.  Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. , 2001, The American journal of pathology.

[97]  N. Gruis,et al.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.

[98]  I. Laird-Offringa,et al.  Epigenetic Events in Lung Cancer: Chromatin Remodeling and DNA Methylation , 2018 .

[99]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[100]  Y. Xie,et al.  Predicative values of serum microRNA-22 and microRNA-126 levels for non-small cell lung cancer development and metastasis: a case-control study. , 2017, Neoplasma.